BRIEF published on 01/28/2025 at 07:05, 10 months 7 days ago Changes to the Board of Directors of Cembra Annual General Meeting Board Changes Cembra Monica Mächler Wanda Eriksen
PRESS RELEASE published on 01/28/2025 at 07:00, 10 months 7 days ago Changes to the Board of Directors of Cembra Dr Monica Mächler to leave the Board of Directors of Cembra at the end of current term. Wanda Eriksen nominated as successor for election at 2025 AGM. Cembra undergoes board change Board Of Directors Financial Services Cembra Monica Mächler Wanda Eriksen
BRIEF published on 08/30/2024 at 07:05, 1 year 3 months ago Cembra Opts Against Early Redemption of Additional Tier 1 Bond Financial Announcement Redemption Cembra Money Bank Interest Rate AT1 Bond
PRESS RELEASE published on 08/30/2024 at 07:00, 1 year 3 months ago Cembra decides not to call Additional Tier 1 bond Cembra Money Bank AG announces decision not to call Additional Tier 1 bond, citing terms of bond issuance and future redemption possibilities Redemption Cembra Money Bank AG Prospectus Additional Tier 1 Bond Swiss Bank
BRIEF published on 07/24/2024 at 06:35, 1 year 4 months ago Cembra Achieves 6% Growth in Net Revenues and 4% Rise in Net Income in H1 2024 Net Income Strategic Transformation Net Revenues Cost/income Ratio Interest Income
PRESS RELEASE published on 07/24/2024 at 06:30, 1 year 4 months ago Cembra reports growth in net revenues of 6% and net income of 4% in the first half year Cembra Money Bank AG reports 6% growth in net revenues and 4% increase in net income for the first half of 2024. Strategic transformation milestones and financial outlook shared Net Income Financial Outlook Cembra Money Bank AG Strategic Transformation Net Revenues
BRIEF published on 04/24/2024 at 16:00, 1 year 7 months ago Cembra Money Bank AG's Shareholders Meeting Results Board Of Directors Annual General Meeting Shareholder Approval Dividend Increase Cembra Money Bank
PRESS RELEASE published on 04/24/2024 at 15:55, 1 year 7 months ago Cembra shareholders approve all proposals of the Board of Directors Cembra Money Bank AG shareholders approve all proposals at Annual General Meeting 2024, including dividend increase and new Board member election Board Of Directors Annual General Meeting Shareholders Dividend Increase Cembra Money Bank AG
BRIEF published on 03/21/2024 at 07:05, 1 year 8 months ago Cembra Announces Annual General Meeting 2024 Plans and Releases Annual Report 2023 Board Of Directors Annual General Meeting 2024 Annual Report 2023 Cembra Money Bank AG External Auditor
PRESS RELEASE published on 03/21/2024 at 07:00, 1 year 8 months ago Cembra publishes invitation to the Annual General Meeting 2024 and its Annual Report 2023 Cembra Money Bank AG publishes invitation to the Annual General Meeting 2024 and Annual Report 2023, announces new Board member and changes in auditors Board Of Directors Annual General Meeting Annual Report 2023 Cembra Money Bank AG External Auditor
Published on 12/05/2025 at 02:35, 4 hours 18 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 53 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 48 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 53 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 23 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 2 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 28 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 38 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 42 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 53 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 8 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 9 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 52 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
